Global footprint Mimotopes has a long-standing global reach with sales offices and distribution channels across the US, UK, Europe, Japan, and India, presenting opportunities for regional partnerships, distributor engagement, and cross-border collaborations.

Elite capabilities As a 30-year leader in Custom Peptide Technology and Antibody Production with proprietary synthesis and protease profiling technologies, Mimotopes represents a strong platform for outsourcing high-complexity biomolecular services and collaboration on R&D projects.

Growth potential With revenue in the mid-range of 10–25 million and a lean employee base, there is room to scale through strategic partnerships, expanded service lines, and targeted pharma/biotech contracts that leverage their library and immobilisation technologies.

Innovation edge Proprietary technologies such as Peptide Library Technology, Synphase Quantitative Solid Phase Chemistry, and REPLi Protease Profiling offer differentiators for customers seeking advanced discovery, screening, and profiling capabilities.

Full-service enablement Strong pre- and post-sale support and post-graduate friendly culture indicate a focus on customer success and long-term relationships, creating opportunities to upsell additional services, training, and technical support contracts.